Schedule 13G ownership disclosure

MABVAX THERAPEUTICS HLDGS INC COM

Security class unavailable · CUSIP: 55414P108

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-16-004675
Form type
SC 13G/A
Filer
FROST PHILLIP MD ET AL
CIK
CIK 898860
Filed
Feb 08, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub